The share structure here is small - huh? What about all the overhang on the toxic convertible notes?:
O/S shares = 184.7 million Outstanding convertible debt potential and other obligations: $230k due at end of 2012 = about 53 million shares $41k to MMRI convertible to preferred stock $500k note to 10 investors - currently in default $23k remaining on Dec. 2011 convertible note $169k remaining on Oct-Mar convertible notes $54.5 remaining on Mar 2012 convertible note $245k remaining on Jan convertible note $22k to Neurotrophics $150k to Dr. Herschkowitz 500k stock options (fully vested) issued in November to a consultant Pending lawsuit for Peter Freeman for financial overhang on convertible debt 10.7 million share stock option plan
The Board has also recently authorized the issuance of 2.5 million preferred shares (out of a total of 10 million potentially available) - each of the preferred shares have a voting right equivalent to 50 common shares (equivalent to 125 million shares).
Market Data 
Markets 
AI
